Clinical Trial Summary Result Information

Clinical trial summary result Information from completed trials in the English-language are available below and on TakedaClinicalTrials.com

If you are a patient, physician, or researcher seeking more information about Takeda's completed clinical trials in the Japanese language please click here.


Search

TAK-491(01-05-TL-491-008)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension
clinicaltrials.gov/ct2/show/results/NCT00696241

AG-1749/CCT-352

A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric and Duodenal Ulcers During Long-term Treatment With Nonsteroid Anti-inflammatory Drug
clinicaltrials.gov/ct2/show/results/NCT00787254

TAK-491(01-05-TL-491-005)

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study of the Efficacy, Safety and Tolerability of TAK-491 in Subjects With Mild to Moderate Uncomplicated Essential Hypertension&nb...
clinicaltrials.gov/ct2/show/results/NCT00362115

Dexlansoprazole (T-P107-163)

A Phase 1, Randomized, Open-Label, Parallel Group, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole Modified Release Capsules (30 mg and 60 mg) in Adolescents With Symp...
clinicaltrials.gov/ct2/show/results/NCT00847210

Febuxostat (C02-009)

A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.
clinicaltrials.gov/ct2/show/NCT00174915

Alogliptin (SYR-322-SULF-007)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabe...
clinicaltrials.gov/ct2/show/results/NCT00286468

TAK-390MR(T-GD08-178)

A Phase 3b Multicenter, Single-Blind Trial to Evaluate the Efficacy of Dexlansoprazole MR 30 mg in Maintaining Control of Gastroesophageal Reflux Disease Symptoms in Subjects on Prior Twice Daily Prot...
clinicaltrials.gov/ct2/show/results/NCT00847808

SYR-322-_02

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
clinicaltrials.gov/ct2/show/NCT01289119